• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医疗服务提供者和患者对基层医疗诊所高血压管理多组分干预措施的干预后可接受性:新加坡一项整群随机对照试验的定性研究

Post-Intervention Acceptability of a Multicomponent Intervention for Hypertension Management in Primary Care Clinics by Health Care Providers and Patients: A Qualitative Study of a Cluster RCT in Singapore.

作者信息

Jafar Tazeen H, Tan Ngiap Chuan, Shirore Rupesh M, Ramakrishnan Chandrika, Yoon Sungwon, Chen Christina, Aravindhan Amudha

机构信息

Program in Health Services & Systems Research, Duke-NUS Medical School, Singapore, Singapore.

Department of Renal Medicine, Singapore General Hospital, Singapore, Singapore.

出版信息

Patient Prefer Adherence. 2024 Aug 1;18:1603-1618. doi: 10.2147/PPA.S469855. eCollection 2024.

DOI:10.2147/PPA.S469855
PMID:39104596
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11299726/
Abstract

BACKGROUND

Hypertension is a major public health challenge, globally. Recently, we reported findings from cluster randomized trial in 8 primary care clinics in Singapore and showed that a multicomponent "SingHypertension" intervention comprising 1) motivational conversation by trained nurses, 2) telephone-based follow-ups, 3) standardized algorithm with single-pill combination (SPC) antihypertensive medications, and 4) subsidy on SPC antihypertensive drugs was effective on improving BP control. This paper presents the acceptability of SingHypertension multicomponent intervention among the key stakeholders.

METHODS

We conducted post-implementation interviews of 38 stakeholders, including 18 patients and 20 healthcare providers (HCPs) in 4 primary care clinics randomized to the multicomponent "SingHypertension" intervention in Singapore. We used Theoretical Framework for Acceptability (TFA) framework with a focus on affective attitude, burden, ethicality, intervention coherence, opportunity cost, perceived effectiveness and self-efficacy to assess stakeholders' acceptability of the intervention.

RESULTS

SingHypertension multicomponent intervention had high perceived effectiveness and a good fit with the value system and ethics of patients and HCPs. Physicians appreciated the guidance from standardized training in hypertension management. Although workload was increased, the nurses felt rewarded for their positive interactions with the patients during motivational conversation sessions and the telephone follow-ups. Most patients reported high self-efficacy levels, improved lifestyles, and adherence to antihypertensive medications. The limited choice of SPC medication, lack of subsidy beyond the trial duration, and shortage of nurses were significant challenges to wide-scale implementation. All HCPs and patients supported scaling up the intervention across primary care clinics.

CONCLUSION

SingHypertension multicomponent intervention is acceptable to the key stakeholders in Singapore. Taken together with the effectiveness of the intervention, our findings make a compelling case for scaling-up SingHypertension in primary care clinics in Singapore and possibly other countries with similar healthcare infrastructure.

摘要

背景

高血压是全球主要的公共卫生挑战。最近,我们报告了在新加坡8家基层医疗诊所进行的整群随机试验的结果,结果显示,一种多组分的“SingHypertension”干预措施有效改善了血压控制,该干预措施包括:1)由经过培训的护士进行的激励性谈话;2)电话随访;3)使用单一片剂复方(SPC)抗高血压药物的标准化算法;4)SPC抗高血压药物补贴。本文介绍了关键利益相关者对SingHypertension多组分干预措施的接受程度。

方法

我们对38名利益相关者进行了实施后访谈,其中包括新加坡4家随机接受多组分“SingHypertension”干预措施的基层医疗诊所的18名患者和20名医疗服务提供者(HCP)。我们使用可接受性理论框架(TFA),重点关注情感态度、负担、伦理道德、干预一致性、机会成本、感知有效性和自我效能感,以评估利益相关者对该干预措施的接受程度。

结果

SingHypertension多组分干预措施具有较高的感知有效性,并且与患者和HCP的价值体系及伦理道德高度契合。医生对高血压管理标准化培训的指导表示赞赏。尽管工作量有所增加,但护士们在激励性谈话环节和电话随访中与患者的积极互动中获得了满足感。大多数患者报告自我效能感较高,生活方式得到改善,并且坚持服用抗高血压药物。SPC药物选择有限、试验期之外缺乏补贴以及护士短缺是大规模实施的重大挑战。所有HCP和患者都支持在基层医疗诊所扩大该干预措施的实施范围。

结论

SingHypertension多组分干预措施在新加坡的关键利益相关者中是可接受的。结合该干预措施的有效性,我们的研究结果有力地支持了在新加坡的基层医疗诊所扩大SingHypertension的实施范围,并可能推广到其他具有类似医疗基础设施的国家。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8791/11299726/80b1a32dfad1/PPA-18-1603-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8791/11299726/80b1a32dfad1/PPA-18-1603-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8791/11299726/80b1a32dfad1/PPA-18-1603-g0001.jpg

相似文献

1
Post-Intervention Acceptability of a Multicomponent Intervention for Hypertension Management in Primary Care Clinics by Health Care Providers and Patients: A Qualitative Study of a Cluster RCT in Singapore.医疗服务提供者和患者对基层医疗诊所高血压管理多组分干预措施的干预后可接受性:新加坡一项整群随机对照试验的定性研究
Patient Prefer Adherence. 2024 Aug 1;18:1603-1618. doi: 10.2147/PPA.S469855. eCollection 2024.
2
Integration of a multicomponent intervention for hypertension into primary healthcare services in Singapore-A cluster randomized controlled trial.将一项多组分干预措施整合到新加坡初级医疗保健服务中以治疗高血压-一项群组随机对照试验。
PLoS Med. 2022 Jun 13;19(6):e1004026. doi: 10.1371/journal.pmed.1004026. eCollection 2022 Jun.
3
Management of hypertension and multiple risk factors to enhance cardiovascular health in Singapore: The SingHypertension cluster randomized trial.新加坡高血压及多种危险因素管理以促进心血管健康:新加坡高血压群组随机试验
Trials. 2018 Mar 14;19(1):180. doi: 10.1186/s13063-018-2559-x.
4
Post-intervention acceptability of multicomponent intervention for management of hypertension in rural Bangladesh, Pakistan, and Sri Lanka- a qualitative study.干预后孟加拉国、巴基斯坦和斯里兰卡农村地区高血压管理多组分干预措施的可接受性:一项定性研究。
PLoS One. 2023 Jan 19;18(1):e0280455. doi: 10.1371/journal.pone.0280455. eCollection 2023.
5
Cost-Effectiveness of a Multicomponent Primary Care Intervention for Hypertension.高血压多组分初级保健干预的成本效益。
J Am Heart Assoc. 2024 Apr 16;13(8):e033631. doi: 10.1161/JAHA.123.033631. Epub 2024 Apr 12.
6
Statistical analysis plan for management of hypertension and multiple risk factors to enhance cardiovascular health in Singapore: the SingHypertension pragmatic cluster randomized controlled trial.新加坡高血压和多重危险因素管理以增强心血管健康的实用群组随机对照试验的统计分析计划。
Trials. 2021 Jan 19;22(1):66. doi: 10.1186/s13063-020-05016-4.
7
Management of hypertension and multiple risk factors to enhance cardiovascular health - a feasibility study in Singapore polyclinics.管理高血压和多种风险因素以促进心血管健康——新加坡综合诊疗所的一项可行性研究
BMC Health Serv Res. 2016 Jul 8;16:229. doi: 10.1186/s12913-016-1491-6.
8
Multicomponent intervention versus usual care for management of hypertension in rural Bangladesh, Pakistan and Sri Lanka: study protocol for a cluster randomized controlled trial.多组分干预与常规护理用于孟加拉国、巴基斯坦和斯里兰卡农村地区高血压管理的比较:一项整群随机对照试验的研究方案
Trials. 2017 Jun 12;18(1):272. doi: 10.1186/s13063-017-2018-0.
9
Healthcare professionals' perspectives on facilitators of and barriers to CKD management in primary care: a qualitative study in Singapore clinics.医疗保健专业人员对初级保健中 CKD 管理的促进因素和障碍的看法:新加坡诊所的定性研究。
BMC Health Serv Res. 2022 Apr 26;22(1):560. doi: 10.1186/s12913-022-07949-9.
10
Sexual risk reduction interventions for patients attending sexual health clinics: a mixed-methods feasibility study.针对就诊于性健康诊所的患者的性风险降低干预措施:一项混合方法可行性研究。
Health Technol Assess. 2019 Mar;23(12):1-122. doi: 10.3310/hta23120.

本文引用的文献

1
Cost-Effectiveness of a Multicomponent Primary Care Intervention for Hypertension.高血压多组分初级保健干预的成本效益。
J Am Heart Assoc. 2024 Apr 16;13(8):e033631. doi: 10.1161/JAHA.123.033631. Epub 2024 Apr 12.
2
Social Determinants of Health and Disparities in Hypertension and Cardiovascular Diseases.社会决定因素与高血压和心血管疾病的差异。
Hypertension. 2024 Mar;81(3):387-399. doi: 10.1161/HYPERTENSIONAHA.123.21354. Epub 2023 Dec 28.
3
Integration of a multicomponent intervention for hypertension into primary healthcare services in Singapore-A cluster randomized controlled trial.
将一项多组分干预措施整合到新加坡初级医疗保健服务中以治疗高血压-一项群组随机对照试验。
PLoS Med. 2022 Jun 13;19(6):e1004026. doi: 10.1371/journal.pmed.1004026. eCollection 2022 Jun.
4
Implementation of fixed-dose combination therapy for secondary prevention of atherosclerotic cardiovascular disease among Syrian refugees in Lebanon: a qualitative evaluation.黎巴嫩境内的叙利亚难民二级预防动脉粥样硬化性心血管疾病的固定剂量联合治疗实施情况:定性评估。
BMC Health Serv Res. 2022 Jun 4;22(1):744. doi: 10.1186/s12913-022-08040-z.
5
The acceptability of integrated healthcare services for HIV and non-communicable diseases: experiences from patients and healthcare workers in Tanzania.艾滋病毒和非传染性疾病综合医疗服务的可接受性:来自坦桑尼亚患者和卫生保健工作者的经验。
BMC Health Serv Res. 2022 May 16;22(1):655. doi: 10.1186/s12913-022-08065-4.
6
Healthcare professionals' perceptions of the role of a multidisciplinary approach in improving the care of patients with advanced chronic kidney disease.医疗保健专业人员对多学科方法在改善晚期慢性肾脏病患者护理中的作用的看法。
Int Urol Nephrol. 2020 Dec;52(12):2357-2365. doi: 10.1007/s11255-020-02571-2. Epub 2020 Aug 1.
7
Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家慢性肾脏病负担,1990-2017 年:2017 年全球疾病负担研究的系统分析。
Lancet. 2020 Feb 29;395(10225):709-733. doi: 10.1016/S0140-6736(20)30045-3. Epub 2020 Feb 13.
8
Communication skills training for physicians improves health literacy and medical outcomes among patients with hypertension: a randomized controlled trial.医师沟通技巧培训可提高高血压患者的健康素养和医疗结局:一项随机对照试验。
BMC Health Serv Res. 2020 Jan 23;20(1):60. doi: 10.1186/s12913-020-4901-8.
9
Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys.12 个高收入国家高血压知晓率、治疗率和控制率的长期和近期趋势:对 123 项全国代表性调查的分析。
Lancet. 2019 Aug 24;394(10199):639-651. doi: 10.1016/S0140-6736(19)31145-6. Epub 2019 Jul 18.
10
Fixed-dose combination pharmacologic therapy to improve hypertension control worldwide: Clinical perspective and policy implications.固定剂量复方药物治疗以改善全球高血压控制:临床视角与政策影响
J Clin Hypertens (Greenwich). 2019 Jan;21(1):4-15. doi: 10.1111/jch.13426. Epub 2018 Nov 27.